-- Orthocell（ASX：OCC）周五向澳大利亚证券交易所提交的文件显示，该公司在美国国防部/退伍军人事务部医院网络内位于俄亥俄州的一家军事基地医院进行的手术，是其神经修复产品Remplir的首例应用案例。 该公司表示，这标志着其美国商业化战略迈出了重要一步。
Related Articles
Asia
ASX Midday Sector Update: Information Technology Shares Gain, Consumer Discretionary Falls
Information technology stocks were leading gainers with a rise of 1.4% in midday trading on Friday.WiseTech Global (ASX:WTC) was up nearly 4%, and Xero (ASX:XRO) was marginally higher.On the flip side, consumer discretionary stocks were down 0.8% to lead decliners.Kmart owner Wesfarmers (ASX:WES) was shedding more than 1%, while Aristocrat Leisure (ASX:ALL) fell nearly 1%.
$^AXJO$ASX:ALL$ASX:WES$ASX:WTC$ASX:XRO
Asia
Huayou Cobalt's Q1 Profit Jumps 99%, Revenue Climbs 45%; Shares Rise 3%
Zhejiang Huayou Cobalt's (SHA:603799) net profit attributable to shareholders in the first quarter jumped 99% to 2.50 billion yuan from 1.25 billion yuan a year earlier, according to a Shanghai bourse filing on Friday.Earnings per share rose 89% year on year to 1.32 yuan from 0.70 yuan.Operating revenue climbed 45% to 25.8 billion yuan from 17.8 billion yuan in the previous year.The battery manufacturer's shares rose less than 3% in morning trade Friday.
$SHA:603799
Asia
NZX Most Active Stocks
Here are the most actively traded stocks on New Zealand's Exchange on Friday.Kiwi Property Group (NZE:KPG): 2.3 million sharesArgosy Property (NZE:ARG): 1.6 million sharesSpark New Zealand (NZE:SPK): 1.2 million sharesFletcher Building (NZE:FBU): 908,737 sharesOceania Healthcare (NZE:OCA): 845,665 shares
$^NZ50$NZE:ARG$NZE:FBU$NZE:KPG$NZE:OCA$NZE:SPK